Clinical Trial

Span-C-SBRT for Pancreatic Cancer

Study acronym: Span-C
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To assess the freedom from local failure at 12 months after Stereotactic Body Radiotherapy (SBRT). Also to assess the safety, efficacy and feasibility of SBRT in the treatment of high risk localised pancreatic cancer.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2018-04-16; most recent amendment 2026-01-27.
Status change: Recruiting → Active, Not Recruiting 2026-01-27
Status change: Not Yet Recruiting → Recruiting 2019-01-06
Trial Details
NCT Number NCT03505229
Lead Sponsor Royal North Shore Hospital
Conditions High Risk Localised Pancreatic Cancer
Enrollment 30 participants
Start Date 2018-12-18
Primary Completion 2028-10-05 (estimated)
Study Completion 2028-10-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-29